Please use this identifier to cite or link to this item: https://doi.org/10.1177/0091270009332813
Title: Mechanism-Based Enterohepatic Circulation Model of Mycophenolic Acid and Its Glucuronide Metabolite: Assessment of Impact of Cyclosporine Dose in Asian Renal Transplant Patients
Authors: Yau, Wai-Ping 
Vathsala, Anantharaman 
Lou, Huei-Xin
Zhou, Shufeng
Chan, Eli 
Keywords: Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
Mycophenolic acid
pharmacokinetic modeling
enterohepatic circulation
renal transplant
cyclosporine
POPULATION PHARMACOKINETIC ANALYSIS
RESISTANCE-ASSOCIATED PROTEIN-2
RANDOMIZED-TRIAL
ACUTE REJECTION
MOFETIL
RECIPIENTS
TACROLIMUS
PREVENTION
KIDNEY
COMBINATION
Issue Date: 1-Jun-2009
Publisher: WILEY
Citation: Yau, Wai-Ping, Vathsala, Anantharaman, Lou, Huei-Xin, Zhou, Shufeng, Chan, Eli (2009-06-01). Mechanism-Based Enterohepatic Circulation Model of Mycophenolic Acid and Its Glucuronide Metabolite: Assessment of Impact of Cyclosporine Dose in Asian Renal Transplant Patients. JOURNAL OF CLINICAL PHARMACOLOGY 49 (6) : 684-699. ScholarBank@NUS Repository. https://doi.org/10.1177/0091270009332813
Abstract: Mycophenolic acid (MPA) is mainly metabolized to MPA-glucuronide (MPAG), which may be reconverted to MPA following enterohepatic circulation (EHC). A physiologically realistic EHC model was proposed to estimate and assess the impact of cyclosporine (CsA) dose on the extent of EHC of MPA and MPAG. After the first oral dose of mycophenolate mofetil (MMF), theMPA and MPAG plasma concentration-time data of 14 adult renal transplant patients (12 receiving concomitant CsA and prednisolone and 2 receiving only concomitant prednisolone without CsA) were analyzed by individual pharmacokinetic modeling using a proposed 5-compartment drug and metabolite EHC model with a time-varying gallbladder emptying process. Simulations were performed to assess the influence of the time of bile release after dosing (T bile) and the gallbladder emptying interval (τ gall) on the EHC process. The extent of EHC for both MPA and MPAG tended to be lower in the group receiving CsA coadministration and decreased with increasing total body weight-adjusted CsA dose. Simulations revealed that T bjle and τ gall influenced the time of occurrence and maximum concentration of the second peak, as well as the extent of EHC, for MPA and MPAG. © 2009 the American College of Clinical Pharmacology.
Source Title: JOURNAL OF CLINICAL PHARMACOLOGY
URI: https://scholarbank.nus.edu.sg/handle/10635/229442
ISSN: 0091-2700
1552-4604
DOI: 10.1177/0091270009332813
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Mechanism-based EHC model of MPA MPAG (JCP).pdf1.03 MBAdobe PDF

CLOSED

Published

SCOPUSTM   
Citations

25
checked on Sep 23, 2022

Page view(s)

28
checked on Sep 29, 2022

Download(s)

3
checked on Sep 29, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.